ICG1_ed-5 Publications of the last five years

  1. Naumenko V.S., Ponimaskin E. Palmitoylation as a Functional Regulator of Neurotransmitter Receptors // Neural Plasticity. 2018:5701348.
  2. Ilchibaeva T.V., Tsybko A.S., Kozhemyakina R.V., Kondaurova E.M., Popova N.K., Naumenko V.S. Genetically defined fear-induced aggression: focus on BDNF and its receptors // Behav. Brain Res. 2018;343:102-110.
  3. Kulikov A.V., Gainetdinov R.R., Ponimaskin E., Kalueff A.V., Naumenko V.S., Popova N.K. Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy // Expert Opinion On Therapeutic Targets. 2018;22(4):319-330..
  4. Knyazev G.G., Savostyanov A.N., Bocharov A.V., Bazovkina D.V., Proshina E.A. Resting State Networks Mediate the Effect of Genotype by Environment Interaction on Mental Health // Neuroscience. 2018;369:139-151.
  5. Kulikova E.A., Kulikov A.V. Kaiso Protein in the Regulation of Brain and Behavior // Curr Protein Pept Sci. 2018;19(7):692-698.
  6. Kulikova E.A., Khotskin N.V., Illarionova N.B., Sorokin I.E., Bazhenova E.Y., Kondaurova E.M., Volcho K.P., Khomenko T.M., Salakhutdinov N.F., Ponimaskin E., Naumenko V.S., Kulikov A.V. Inhibitor of striatal-enriched protein tyrosine phosphatase, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), produces antidepressant-like effect and decreases functional activity and protein level of 5-HT2A receptor in the brain // Neuroscience. 2018;394:220-231.
  7. Kondaurova E., Antonov Y., Pershina A., Bazhenova E., Bazovkina D., Popova N. Acute stress effect on hypothalamus BDNF expression, monoamines levels and adrenal catecholamines in mouse lines differed by 5-HT1A receptor function // European Neuropsychopharmacology. 2018;29:S249-S250.
  8. Voronova I., Khramova G., Bazovkina D., Kulikov A. Involvement of serotonin2A (5-HT2A) receptor and terminal fragment of chromosome 13 in the development of hypothermia in lipopolysaccharide (LPS)-treated mice // European Neuropsychopharmacology. 2018;29:S277.
  9. Bazovkina D., Pershina A., Fursenko D., Khotskin N., Kulikova E., Bazhenova E., Kulikov A. Role of tumor necrosis factor gene in acute lipopolysacharide effect on behavior, brain expression of interleukins and brain serotonin system in mice // European Neuropsychopharmacology. 2018;29:S464.
  10. Kulikova E., Khotskin N., Bazhenova E., Sergiyenko V., Fursenko D., Sorokin I., Kolotygin I., Khotskina A., Kulikov A. Alterations in the expression and activity of STEP in the mouse brain induced by genetically defined obesity and lipopolysaccharide (LPS) administration // European Neuropsychopharmacology. 2018;29:S50-S51.
  11. Kulikov A., Sinyakova N., Kulikova E., Evglevsky N., Kolotygin I., Volcho K., Salakhutdinov N., Kulikov V., Romaschenko A., Moshkin M. Effects of acute and chronic treatment of STEP inhibitor, TC-2153, on the nervous system and behaviour of zebrafish (Danio rerio) // European Neuropsychopharmacology. 2018;S198-S199.
  12. Tsybko A., Ilchibaeva T., Khotskin N., Naumenko V., Popova N. The effect of atypical antipsychotic drugs on the neurotrophic factors gene expression in the MPTP model of Parkinson’s disease // European Neuropsychopharmacology. 2018;29:S159-S160.
  13. Ilchibaeva T., Eremin D., Kozhemyakina R., Naumenko V., Tsybko A. Implication of the brain dopamine system in the regulation of genetically-defined aggressive behavior in rats // European Neuropsychopharmacology. 2018;29:S556-S557.
  14. Khotskin N.V., Plyusnina A.V., Kulikova E.A., Bazhenova E.Yu, Fursenko D.V., Sorokin I.E., Kolotygin I., Mormede P., Terenina E.E., Shevelev O.B., Kulikov A.V. On association of the lethal yellow (AY ) mutation in the agouti gene with the alterations in mouse brain and behavior. Behavioural Brain Research. 2018; 359:446-456.
  15. Kulikova EA, Kulikov AV. Kaiso protein in the regulation of brain and behavior // Curr Protein Pept Sci. 2018;19(7):692-698.
  16. Kulikova E.A., Bazovkina D.V., Antonov Y.V., Akulov A.E., Kulikov A.V., Kondaurova E.M. Alteration of the brain morphology and the response to the acute stress in the recombinant mouse lines with different predisposition to catalepsy // Neuroscience Research. 2017;117:14-21.
  17. Bazhenova E.Y., Bazovkina D.V., Kulikova E.A., Fursenko D.V., Khotskin N.V., Lichman D.V., Kulikov A.V. C1473G polymorphism in mouse tryptophan hydroxylase-2 gene in the regulation of the reaction to emotional stress // Neuroscience Letters. 2017;640:105–110.
  18. Bazhenova E.Y., Sinyakova N.A., Kulikova E.A., Kazarinova I.A., Bazovkina D.V., Gainetdinov R.R., Kulikov A.V. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice // Neuroscience Letters. 2017;V.653:264–268.
  19. Tsybko A.S., Ilchibaeva T.V., Popova N.K. Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders // Rev Neurosci. 2017;28(3):219-233.
  20. Kulikova E.A., Volcho K.P., Salakhutdinov N.F., Kulikov A.V. Benzopentathiepine derivative, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), as a promising antidepressant of new generation  // Lett Drug Des Discov. 2017;14(8):974-984.
  21. Kulikova E.A., Kulikov A.V. Striatal-enriched tyrosine protein phosphatase (STEP) in the mechanisms of depressive disorders // Curr Protein Pept Sc. 2017;18(11):1152-1162.
  22. Ilchibaeva T.V., Tsybko A.S., Kozhemyakina R.V., Konoshenko M.Y., Popova N.K., Naumenko V.S. The relationship between different types of genetically defined aggressive behavior // J Ethol. 2017;35(1):75–81.
  23. Knyazev G.G., Bazovkina D.V., Savostyanov A.N., Naumenko V.S., Kuznetsova V.B., Proshina EA. Suppression mediates the effect of 5-HTTLPR by stress interaction on depression // Scand J Psychol. 2017;58(5):373-378.
  24. Knyazev GG, Savostyanov AN, Bocharov AV, Bazovkina DV, Proshina EA. Resting State Networks Mediate the Effect of Genotype by Environment Interaction on Mental Health // Neurosci. 2017;369:139-151.
  25. Ilchibaeva T.V., Tsybko A.S., Kozhemyakina R.V., Popova N.K., Naumenko V.S. Glial cell line-derived neurotrophic factor (GDNF) in genetically defined fear-induced aggression // Eur J Neurosci. 2016;44(7):2467-2473.
  26. Kondaurova EM, Ilchibaeva TV, Tsybko AS, Kozhemyakina RV, Popova NK, Naumenko VS. 5-HT1A receptor gene silencers Freud-1 and Freud-2 are differently expressed in the brain of rats with genetically determined high level of fear-induced aggression or its absence // Behav Brain Res. 2016;310:20-25.
  27. Kulikova EA, Bazovkina DV, Akulov AE, Tsybko AS, Fursenko DV, Kulikov AV, Naumenko VS, Ponimaskin E, Kondaurova EM. Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: role of the 5-HT1A receptor. // Br J Pharmacol. 2016;173(13):2147-61.
  28. Kulikov AV, Bazhenova EY, Kulikova EA, Fursenko DV, Trapezova LI, Terenina EE, Mormede P, Popova NK, Trapezov OV Interplay between aggression, brain monoamines and fur color mutation in the American mink Genes Brain Behav. 2016;15(8):733-740.
  29. Kulikov A.V., Korostina V.S., Kulikova E.A., Fursenko D.V., Akulov A.E., Moshkin M.P., Prokhortchouk E.B. Knockout Zbtb33 gene results in an increased locomotion,exploration and pre-pulse inhibition in mice // Behav Brain Res. 2016;297, P.76-83
  30. Voronova I.P., Khramova G.M., Kulikova E.A., Petrovskii D.V., Bazovkina D.V., Kulikov A.V. 5-HT2A receptors control body temperature in mice during LPS-induced inflammation via regulation of NO production // Pharmacological research. 2016;103, P.123-31
  31. Naumenko VS, Kulikov AV, Kondaurova EM, Tsybko AS, Kulikova EA, Krasnov IB, Shenkman BS, Sychev VN, Bazhenova EY, Sinyakova NA, Popova NK. Effect of actual long-term spaceflight on BDNF, TrkB, p75, BAX and BCL-XL genes expression in mouse brain regions // Neurosci. 2015;284:730-736.
  32. Popova N.K., Kulikov A.V., Kondaurova E.M., Tsybko A.S., Kulikova E.A., Krasnov I.B., Shenkman B.S., Bazhenova E.Yu., Sinyakova N.A., Naumenko V.S. Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system // Mol. Neurobiol. 2015;51(3):1443-51.
  33. Ilchibaeva TV., Kondaurova EM, Tsybko AS, Kozhemyakina RV, Popova NK, Naumenko VS. Brain-derived neurotrophic factor (BDNF) and its precursor (proBDNF) in genetically defined fear-induced aggression // Behav Brain Res. 2015;290:45–50.
  34. Tsybko A.S., Ilchibaeva T.V., Kulikov A.V., Kulikova E.A., Krasnov I.B., Sychev V.N., Shenkman B.S., Popova N.K., Naumenko V.S. Effect of microgravity on glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor gene expression in the mouse brain // J Neurosci Res. 2015;93:1399–1404.
  35. Bazovkina DV, Kondaurova EM, Naumenko VS, Ponimaskin E. Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity // Neural Plast. 2015:846589.
  36. Il’chibaeva T.V., Tsybko A.S., Naumenko V.S. The role of genotype in the effects of chronic 5-HT1A receptor activation with the selective agonist 8-OH-DPAT // Int. J. Dev Neurosci. 2015;47:35.
  37. Kondaurova E.M., Naumenko V.S., Bazovkina D.V., Tsybko A.S., Il’chibaeva T.V. 5-HT1A receptor gene in behavioral effects of brain-derived neurotrophic factor // Int. J. Dev Neurosci. 2015;47:9-10.
  38. Naumenko V.S., Kondaurova E.M., Tsybko A.S., Il’chibaeva T.V., Bazovkina D.V. Effect of GDNF on the brain dopamine system in genetically predisposed to behavioral disorders mouse strains // Int. J. Dev Neurosci. 2015;47:10.
  39. Tsybko A.S., Il’chibaeva T.V., Kondaurova E.M., Bazovkina D.V., Naumenko V.S. Implication of the serotonin 5-HT2A receptors in the correction of the pathological behavior by the neurotrophic factors BDNF and GDNF // Int. J. Dev Neurosci.2015;47:23.
  40. Bazovkina DV, Lichman DV, Kulikov AV. The C1473G polymorphism in the Tryptophan hydroxylase-2 gene: involvement in ethanol-related behavior in mice // Neurosci Lett. 2015. 589:79-82.
  41. Kulikov AV, Popova NK. Tryptophan hydroxylase 2 in seasonal affective disorder: underestimated perspectives? // Rev Neurosci. 2015;26(6):679-90.
  42. Kulikov AV, Korostina VS, Kulikova EA, Fursenko DV, Akulov AE, Moshkin MP, Prokhortchouk EB. Knockout Zbtb33 gene results in an increased locomotion, exploration and pre-pulse inhibition in mice // Behav Brain Res. 2015;297:76-83.
  43. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Il’chibaeva T.V., Popova N.K. On the role of 5-HT1A receptor gene in behavioral effect of Brain-Derived Neurotrophic Factor // J. Neurosci. 2014;92:1035-1043.
  44. Naumenko V.S., Popova N.K., Lacivita E., Leopoldo M., Ponimaskin E.G. Interplay between Serotonin 5-HT1A and 5-HT7 Receptors in Depressive Disorders // CNS Neurosci. 2014;20(7):582-590.
  45. Kulikov A.V., Fursenko D.V., Hotskin N.V., Bazovkina D.V., Kulikov V.A., Naumenko V.S., Bazhenova E.Yu., Popova N.K. Spatial learning in the Morris water maze in mice genetically different in the predisposition to catalepsy: the effect of intraventricular treatment with brain-derived neurotrophic factor // Pharmacol. Behav. 2014;122:266-272.
  46. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Ilchibaeva T.V., Khotskin N.V., Semenova A.A., Popova N.K. Effect of GDNF on depressive-like behavior, spatial learning and key genes of the brain dopamine system in genetically predisposed to behavioral disorders mouse strains // Behav. Res. 2014;274:1-9.
  47. Kulikov A.V., Tikhonova M.A., Kulikova E.A., Volcho K.P., Khomenko T.M., Salakhutdinov N.F., Popova N.K. Antidepressant activity of 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153): comparison with classical antidepressants // Lett Drug Des Discov. 2014;11(2): 169-173.